Company

From a Lund University lab to the bioprocess floor

Cellevate AB is a Swedish biotech company and spin-out of Lund University. We supply Cellevat3d® nanofiber cell culture products to CDMOs and biopharmaceutical companies worldwide, ISO 9001:2015 certified with GMP processes in a clean room.

A

Management team

Karsten Fjärstedt

Interim CEO

30+ years in operations, marketing, sales and commercialization in biotech and bioprocessing. Formerly Business Unit lead at GE Healthcare (now Cytiva), CEO of Denator and COO of Bio-Works. MSc Chemical Technology, KTH.

Christel Fenge, PhD

CTO

30+ years across bioprocessing: VP R&D Bioprocess at Cytiva, VP Marketing and Product Management Fermentation Technologies at Sartorius, General Manager of Recipharm Biologics, earlier AstraZeneca and Pharmacia & Upjohn.

Linda Dexlin Mellby, PhD

COO

13+ years leading R&D organizations in diagnostics, most recently VP Research and Development at Immunovia. PhD in Immunotechnology.

Déspina Georgiadou Hedin

CFO

15+ years in finance roles across biotech, nanotech and financial services, including CFO at Opticept Technologies, Ascelia Pharma and Bioglan.

Nils Uhlin

Sales & Marketing Director

20+ years in life science sales and marketing, including Immunovia, Menarini Nordics and Dako (now Agilent Technologies).

Board of Directors chaired by Uwe Gottschalk. On 23 March 2026 the board appointed Karsten Fjärstedt Interim CEO and started the search for a permanent CEO.

B

News

C

Contact

Cellevate AB
Lund, Sweden

Orders and product questions: sales@cellevate.com
Everything else: our contact form.

Cellevat3d nanofiber microcarriers starter packCell spheroids on Cellevat3d microcarriers, brightfield and fluorescence
The starter pack and what grows on it.